— Know what they know.
Not Investment Advice

TXG NASDAQ

10x Genomics, Inc.
1W: +14.7% 1M: +8.1% 3M: +30.7% YTD: +48.5% 1Y: +171.8% 3Y: -52.7% 5Y: -82.8%
$23.68
-1.00 (-4.05%)
 
Weekly Expected Move ±9.2%
$17 $19 $21 $23 $25
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Buy · Power 62 · $3.0B mcap · 115M float · 2.18% daily turnover · Short 63% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
59.3 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -7.1%  ·  5Y Avg: -47.0%
Cost Advantage
45
Intangibles
81
Switching Cost
53
Network Effect
62
Scale
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TXG has a Narrow competitive edge (59.3/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. Negative ROIC of -7.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$22
Low
$22
Avg Target
$22
High
Based on 1 analyst since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 11Sell: 1Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$25.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-12 Morgan Stanley $20 $22 +2 +6.8% $20.60
2026-04-14 Barclays $22 $30 +8 +27.2% $23.58
2026-03-02 Stifel Nicolaus Daniel Arias $20 $25 +5 +11.7% $22.38
2026-02-20 UBS $13 $20 +7 +4.2% $19.19
2026-02-13 Deutsche Bank $14 $17 +3 -12.4% $19.40
2026-02-13 Stifel Nicolaus Initiated $20 +14.2% $17.51
2026-02-13 Canaccord Genuity Kyle Mikson $20 $22 +2 +25.6% $17.51
2026-01-12 Needham Initiated $21 +2.6% $20.46
2025-12-22 Canaccord Genuity $16 $20 +4 +24.6% $16.05
2025-12-15 Barclays $24 $22 -2 +42.4% $15.45
2025-12-01 Morgan Stanley Kallum Titchmarsh $46 $20 -26 +10.6% $18.08
2025-08-11 Canaccord Genuity Kyle Mikson $32 $16 -16 +29.1% $12.39
2025-08-08 UBS Dan Leonard Initiated $13 +8.1% $12.03
2025-08-08 Deutsche Bank Justin Bowers $25 $14 -11 +13.9% $12.29
2024-08-13 Morgan Stanley Tejas Savant Initiated $46 +134.1% $19.65
2024-07-23 Canaccord Genuity Kyle Mikson Initiated $32 +76.7% $18.11
2024-07-10 Deutsche Bank Justin Bowers $50 $25 -25 +37.0% $18.25
2024-06-28 Barclays Luke Sergott $36 $24 -12 +20.9% $19.85
2024-06-02 Jefferies Tycho Peterson Initiated $24 +7.0% $22.42
2024-05-01 Barclays Luke Sergott $45 $36 -9 +23.0% $29.28
2024-04-10 Barclays Luke Sergott Initiated $45 +20.4% $37.37
2022-12-14 Deutsche Bank Initiated $50 +42.0% $35.21

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
4
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TXG receives an overall rating of C+. Strongest factors: DCF (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-11 C C+
2026-04-01 C+ C
2026-02-24 C C+
2026-02-18 C- C
2026-02-13 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

57 Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
39
Growth
69
Value
37
Momentum
66
Safety
100
Cash Flow
70
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TXG scores highest in Safety (100/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.78
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.53
Unlikely Manipulator
Ohlson O-Score
-10.07
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 71.9/100
Trend: Improving
Earnings Quality
OCF/NI: -5.64x
Accruals: -15.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TXG scores 5.78, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TXG scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TXG's score of -2.53 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TXG's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TXG receives an estimated rating of A (score: 71.9/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-134.09x
PEG
-0.53x
P/S
4.71x
P/B
3.73x
P/FCF
22.29x
P/OCF
21.31x
EV/EBITDA
-400.53x
EV/Revenue
3.69x
EV/EBIT
-84.85x
EV/FCF
19.30x
Earnings Yield
-0.83%
FCF Yield
4.49%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TXG currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.177
NI / EBT
×
Interest Burden
0.693
EBT / EBIT
×
EBIT Margin
-0.044
EBIT / Rev
×
Asset Turnover
0.652
Rev / Assets
×
Equity Multiplier
1.301
Assets / Equity
=
ROE
-3.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TXG's ROE of -3.0% is driven by Asset Turnover (0.652), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.18 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1683 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$23.68
Median 1Y
$16.85
5th Pctile
$6.22
95th Pctile
$45.46
Ann. Volatility
66.7%
Analyst Target
$25.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Serge Saxonov
Chief Executive Officer
$674,250 $5,020,269 $6,329,244
Eric S. Whitaker
Former Chief Legal Officer
$518,654 $2,629,967 $3,441,571
Benjamin J. Hindson
President and Chief Scientific Officer
$518,654 $1,793,155 $2,604,759
Adam S. Taich
Chief Financial Officer
$507,461 $1,441,065 $2,233,107

CEO Pay Ratio

24:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,329,244
Avg Employee Cost (SGA/emp): $268,365
Employees: 1,178

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,178
-9.8% YoY
Revenue / Employee
$545,690
Rev: $642,823,000
Profit / Employee
$-36,964
NI: $-43,544,000
SGA / Employee
$268,365
Avg labor cost proxy
R&D / Employee
$202,574
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -87.0% -78.6% -7.5% -11.4% -18.3% -21.5% -20.5% -21.5% -21.2% -27.5% -33.0% -34.2% -31.0% -23.6% -25.2% -21.6% -11.7% -10.5% -5.8% -3.0% -3.01%
ROA -65.7% -59.3% -6.0% -9.1% -14.6% -17.2% -16.2% -17.0% -16.8% -21.8% -25.6% -26.5% -24.0% -18.3% -19.4% -16.7% -9.0% -8.1% -4.4% -2.3% -2.31%
ROIC -2.8% -2.5% -13.2% -21.2% -34.6% -40.7% -28.2% -29.9% -29.9% -39.1% -46.8% -48.5% -44.7% -35.3% -38.5% -34.1% -19.9% -18.1% -11.2% -7.1% -7.10%
ROCE -60.9% -54.9% -5.8% -9.2% -15.1% -17.7% -18.0% -18.9% -18.6% -24.3% -29.7% -30.7% -27.8% -21.0% -22.2% -19.2% -9.9% -9.1% -5.0% -3.1% -3.13%
Gross Margin 95.8% 80.4% 80.8% 77.7% 75.8% 76.8% 76.4% 73.3% 67.8% 62.2% 62.9% 65.9% 68.1% 70.2% 67.2% 68.1% 72.3% 67.3% 68.1% 70.4% 70.39%
Operating Margin -8.9% -12.7% -11.0% -36.5% -55.1% -30.5% -14.8% -38.7% -43.2% -61.7% -30.0% -43.6% -27.3% -27.4% -30.2% -25.4% 17.4% -21.6% -11.8% -11.3% -11.30%
Net Margin -9.5% -13.7% -12.9% -37.0% -56.2% -32.0% -11.0% -37.8% -42.5% -60.5% -26.6% -42.5% -24.8% -23.6% -29.7% -22.2% 20.0% -18.4% -9.8% -8.9% -8.93%
EBITDA Margin -2.2% -7.3% -5.9% -29.3% -48.2% -24.3% -5.0% -30.5% -33.3% -52.3% -19.0% -32.8% -17.1% -15.6% -22.9% -15.3% 27.0% -10.7% -11.8% -11.3% -11.30%
FCF Margin -65.0% -55.2% -25.0% -25.8% -32.4% -32.0% -32.0% -23.3% -20.7% -19.0% -10.3% -11.8% -5.3% 4.0% -1.1% 7.1% 8.8% 12.7% 20.2% 19.1% 19.13%
OCF Margin -46.0% -34.3% -4.4% -7.6% -11.7% -8.2% -6.5% -3.2% -2.0% -4.6% -2.5% -4.3% -1.2% 6.2% 1.1% 9.1% 10.4% 13.8% 21.2% 20.0% 20.01%
ROE 3Y Avg snapshot only -20.21%
ROE 5Y Avg snapshot only -18.63%
ROA 3Y Avg snapshot only -15.55%
ROIC 3Y Avg snapshot only -42.52%
ROIC Economic snapshot only -3.25%
Cash ROA snapshot only 12.27%
Cash ROIC snapshot only 29.68%
CROIC snapshot only 28.37%
NOPAT Margin snapshot only -4.79%
Pretax Margin snapshot only -3.01%
R&D / Revenue snapshot only 36.20%
SGA / Revenue snapshot only 45.83%
SBC / Revenue snapshot only 15.76%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -42.68 -35.45 -286.28 -96.46 -36.07 -19.43 -25.19 -37.00 -37.83 -21.74 -26.01 -16.95 -9.74 -14.93 -9.56 -6.82 -17.04 -19.22 -47.60 -120.22 -134.090
P/S Ratio 53.03 35.15 33.98 17.22 10.32 6.45 8.10 12.03 11.47 8.22 10.72 7.16 3.70 4.33 2.86 1.71 2.24 2.29 3.22 4.26 4.706
P/B Ratio 29.11 21.84 20.39 10.51 6.29 3.98 5.19 8.01 8.09 6.03 8.95 6.05 3.15 3.68 2.46 1.51 2.03 2.07 2.60 3.42 3.731
P/FCF -81.56 -63.73 -135.90 -66.80 -31.85 -20.18 -25.30 -51.60 -55.36 -43.24 -103.67 -60.59 -69.82 108.86 -259.49 24.13 25.35 17.97 15.93 22.29 22.292
P/OCF 69.60 262.02 18.86 21.54 16.57 15.23 21.31 21.308
EV/EBITDA -44.51 -37.09 -657.15 -150.45 -43.52 -21.25 -29.94 -45.00 -47.73 -25.40 -30.92 -19.90 -10.88 -18.56 -10.71 -6.82 -29.34 -37.53 -136.20 -400.53 -400.535
EV/Revenue 51.55 33.84 32.95 16.20 9.31 5.45 7.45 11.41 10.88 7.65 10.25 6.70 3.23 3.86 2.35 1.22 1.75 1.80 2.66 3.69 3.691
EV/EBIT -42.35 -34.89 -305.83 -96.84 -33.70 -17.05 -23.82 -36.07 -37.11 -20.70 -25.50 -16.30 -8.76 -13.83 -8.08 -4.95 -14.26 -15.82 -38.58 -84.85 -84.852
EV/FCF -79.28 -61.36 -131.78 -62.87 -28.71 -17.04 -23.28 -48.92 -52.52 -40.26 -99.09 -56.63 -61.05 97.15 -213.31 17.12 19.89 14.16 13.12 19.30 19.299
Earnings Yield -2.3% -2.8% -0.3% -1.0% -2.8% -5.1% -4.0% -2.7% -2.6% -4.6% -3.8% -5.9% -10.3% -6.7% -10.5% -14.7% -5.9% -5.2% -2.1% -0.8% -0.83%
FCF Yield -1.2% -1.6% -0.7% -1.5% -3.1% -5.0% -4.0% -1.9% -1.8% -2.3% -1.0% -1.7% -1.4% 0.9% -0.4% 4.1% 3.9% 5.6% 6.3% 4.5% 4.49%
Price/Tangible Book snapshot only 3.734
EV/OCF snapshot only 18.448
EV/Gross Profit snapshot only 5.303
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.56 6.56 6.77 6.77 6.77 6.77 4.85 4.85 4.85 4.85 4.69 4.69 4.69 4.69 4.97 4.97 4.97 4.97 4.46 4.46 4.460
Quick Ratio 6.30 6.30 6.23 6.23 6.23 6.23 4.23 4.23 4.23 4.23 4.11 4.11 4.11 4.11 4.26 4.26 4.26 4.26 4.09 4.09 4.093
Debt/Equity 0.09 0.09 0.10 0.10 0.10 0.10 0.12 0.12 0.12 0.12 0.13 0.13 0.13 0.13 0.12 0.12 0.12 0.12 0.20 0.20 0.198
Net Debt/Equity -0.81 -0.81 -0.62 -0.62 -0.62 -0.62 -0.42 -0.42 -0.42 -0.42 -0.40 -0.40 -0.40 -0.40 -0.44 -0.44 -0.44 -0.44 -0.46 -0.46 -0.459
Debt/Assets 0.07 0.07 0.08 0.08 0.08 0.08 0.09 0.09 0.09 0.09 0.10 0.10 0.10 0.10 0.09 0.09 0.09 0.09 0.15 0.15 0.151
Debt/EBITDA -0.13 -0.15 -3.33 -1.52 -0.77 -0.63 -0.74 -0.70 -0.73 -0.53 -0.46 -0.45 -0.51 -0.73 -0.62 -0.74 -2.14 -2.68 -12.59 -26.79 -26.794
Net Debt/EBITDA 1.28 1.43 20.55 9.40 4.75 3.91 2.61 2.46 2.58 1.88 1.43 1.39 1.56 2.24 2.32 2.79 8.06 10.09 29.18 62.12 62.115
Interest Coverage -431.66 -461.05 -61.03 -108.05 -204.30 -283.42 -339.28 -462.03 -633.48 -1456.17 -7537.27 -17126.47 -21201.18 -14658.83 -44424.00 -51133.33 -15864.40 -12181.33 -7374.83 -4631.50 -4631.500
Equity Multiplier 1.26 1.26 1.25 1.25 1.25 1.25 1.28 1.28 1.28 1.28 1.30 1.30 1.30 1.30 1.29 1.29 1.29 1.29 1.31 1.31 1.308
Cash Ratio snapshot only 3.411
Debt Service Coverage snapshot only -981.167
Cash to Debt snapshot only 3.318
FCF to Debt snapshot only 0.775
Defensive Interval snapshot only 457.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.53 0.60 0.50 0.51 0.51 0.52 0.50 0.52 0.56 0.58 0.62 0.63 0.63 0.63 0.65 0.66 0.68 0.68 0.66 0.65 0.652
Inventory Turnover 2.44 2.89 1.65 1.84 2.34 2.47 1.70 1.85 2.12 2.51 2.70 2.85 2.87 2.71 2.50 2.52 2.51 2.55 2.85 2.78 2.785
Receivables Turnover 9.59 10.86 7.19 7.32 7.30 7.38 5.45 5.66 6.00 6.24 5.65 5.71 5.77 5.75 6.03 6.16 6.36 6.33 9.53 9.47 9.472
Payables Turnover 6.23 7.37 6.72 7.48 9.55 10.08 6.18 6.72 7.72 9.14 11.22 11.87 11.96 11.27 13.70 13.80 13.72 13.96 15.52 15.14 15.145
DSO 38 34 51 50 50 49 67 64 61 59 65 64 63 63 61 59 57 58 38 39 38.5 days
DIO 149 126 222 199 156 148 215 198 172 145 135 128 127 135 146 145 146 143 128 131 131.1 days
DPO 59 50 54 49 38 36 59 54 47 40 33 31 31 32 27 26 27 26 24 24 24.1 days
Cash Conversion Cycle 129 110 218 200 168 161 223 208 185 164 167 161 160 166 180 178 176 175 143 146 145.5 days
Fixed Asset Turnover snapshot only 2.224
Operating Cycle snapshot only 169.6 days
Cash Velocity snapshot only 1.220
Capital Intensity snapshot only 1.630
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 61.4% 75.3% 64.1% 50.0% 22.7% 9.7% 5.3% 7.4% 14.2% 17.3% 19.8% 16.6% 11.1% 6.6% -1.3% -0.1% 2.0% 1.9% 5.2% 2.3% 2.26%
Net Income -5.5% -2.4% 89.3% 83.3% 71.7% 63.3% -1.9% -95.7% -20.9% -33.6% -53.7% -51.6% -39.2% 18.3% 28.4% 40.6% 64.7% 58.2% 76.2% 85.6% 85.57%
EPS -4.8% -2.1% 89.7% 83.9% 72.7% 64.3% -1.8% -91.2% -17.7% -29.5% -48.7% -46.8% -35.3% 20.3% 30.2% 42.1% 66.0% 59.8% 77.2% 86.2% 86.21%
FCF -4.7% -1.4% 52.1% 55.4% 38.8% 36.4% -34.7% 2.8% 27.1% 30.3% 61.3% 40.8% 71.6% 1.2% 89.5% 1.6% 2.7% 2.3% 20.3% 1.8% 1.75%
EBITDA -6.7% -2.7% 95.2% 89.3% 77.3% 69.2% -4.2% -1.5% -21.6% -37.9% -59.6% -54.8% -44.9% 26.4% 34.7% 47.1% 79.5% 76.5% 90.6% 94.7% 94.71%
Op. Income -5.5% -2.4% 90.2% 84.0% 72.4% 64.0% -2.2% -1.1% -30.7% -45.2% -58.0% -54.2% -41.9% 14.3% 26.7% 37.3% 60.3% 54.3% 68.7% 77.5% 77.55%
OCF Growth snapshot only 1.25%
Asset Growth snapshot only 13.36%
Equity Growth snapshot only 12.14%
Debt Growth snapshot only 90.93%
Shares Change snapshot only 4.64%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.0% 55.8% 37.0% 31.3% 31.2% 27.5% 23.4% 15.9% 11.1% 7.6% 7.8% 9.0% 8.4% 7.6% 6.0% 6.01%
Revenue 5Y 59.4% 34.9% 24.6% 20.7% 19.6% 16.6% 13.9% 13.93%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 1.0% 55.9% 36.0% 29.2% 26.1% 19.4% 14.0% 5.2% 2.1% -0.2% 0.8% 4.5% 4.0% 3.9% 3.1% 3.13%
Gross Profit 5Y 55.8% 31.7% 21.5% 18.2% 16.5% 13.1% 10.3% 10.30%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y 96.8%
OCF 3Y
OCF 5Y 21.9% -20.7% 24.9%
Assets 3Y 1.0% 19.3% 19.3% 19.3% 19.3% 1.3% 1.3% 1.3% 1.3% -3.4% -3.4% -3.4% -3.4% 0.4% 0.4% 0.40%
Assets 5Y 50.7% 8.7% 8.7% 8.7% 8.7% 2.3% 2.3% 2.30%
Equity 3Y 24.2% 24.2% 24.2% 24.2% 0.1% 0.1% 0.1% 0.1% -4.6% -4.6% -4.6% -4.6% -0.4% -0.4% -0.39%
Book Value 3Y 17.1% 17.1% 17.6% 18.2% -3.2% -3.0% -2.8% -2.7% -7.2% -7.2% -7.5% -7.6% -3.7% -3.8% -3.78%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 0.99 0.98 0.94 0.93 0.95 0.97 0.92 0.91 0.93 0.99 0.90 0.87 0.90 0.93 0.91 0.88 0.86 0.858
Earnings Stability 0.94 0.01 0.01 0.02 0.30 0.00 0.00 0.00 0.20 0.01 0.01 0.00 0.09 0.00 0.00 0.06 0.18 0.36 0.45 0.452
Margin Stability 0.93 0.95 0.96 0.94 0.94 0.95 0.95 0.93 0.92 0.90 0.89 0.88 0.90 0.90 0.90 0.92 0.92 0.91 0.91 0.906
Rev. Growth Consistency 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.92 0.87 0.50 0.50 0.84 0.93 0.89 0.84 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.32 0.30 0.26 0.26 0.20 0.20 0.21 0.13 -0.21 -0.19 -0.13 -0.01 0.02 0.07 0.15 0.15 0.25 0.26 0.260
Gross Margin Trend 0.09 0.06 0.04 -0.03 -0.04 -0.06 -0.07 -0.09 -0.12 -0.15 -0.15 -0.12 -0.07 -0.04 -0.02 0.00 0.01 0.02 0.03 0.031
FCF Margin Trend -0.36 0.18 0.20 0.09 0.15 0.23 0.33 0.28 0.25 0.18 0.13 0.21 0.29 0.20 0.25 0.22 0.20 0.26 0.21 0.215
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.37 0.35 0.37 0.43 0.41 0.25 0.20 0.10 0.07 0.12 0.06 0.10 0.03 -0.21 -0.04 -0.36 -0.79 -1.16 -3.12 -5.64 -5.642
FCF/OCF 1.41 1.61 5.74 3.38 2.77 3.88 4.92 7.38 10.24 4.12 4.21 2.76 4.30 0.64 -1.01 0.78 0.85 0.92 0.96 0.96 0.956
FCF/Net Income snapshot only -5.393
CapEx/Revenue 19.0% 20.9% 20.6% 18.1% 20.7% 23.7% 25.5% 20.2% 18.7% 14.4% 7.9% 7.5% 4.1% 2.2% 2.2% 2.0% 1.6% 1.1% 0.9% 0.9% 0.88%
CapEx/Depreciation snapshot only 0.257
Accruals Ratio -0.41 -0.39 -0.04 -0.05 -0.09 -0.13 -0.13 -0.15 -0.16 -0.19 -0.24 -0.24 -0.23 -0.22 -0.20 -0.23 -0.16 -0.18 -0.18 -0.15 -0.154
Sloan Accruals snapshot only 0.043
Cash Flow Adequacy snapshot only 22.667
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.0% -0.1% -0.1% -0.2% -0.3% -0.2% -0.2% -0.0% -0.0% -0.0% -0.0% -0.0% -0.3% -0.2% -0.6% -0.9% -0.4% -0.4% -0.2% -0.1% -0.11%
Total Shareholder Return -0.0% -0.1% -0.1% -0.2% -0.3% -0.2% -0.2% -0.0% -0.0% -0.0% -0.0% -0.0% -0.3% -0.2% -0.6% -0.9% -0.4% -0.4% -0.2% -0.1% -0.11%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.02 1.02 1.08 1.06 1.03 1.04 1.02 1.03 1.03 1.02 1.03 1.03 1.03 1.04 1.03 1.02 1.07 1.04 1.09 1.18 1.177
Interest Burden (EBT/EBIT) 1.00 1.00 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.90 0.69 0.693
EBIT Margin -1.22 -0.97 -0.11 -0.17 -0.28 -0.32 -0.31 -0.32 -0.29 -0.37 -0.40 -0.41 -0.37 -0.28 -0.29 -0.25 -0.12 -0.11 -0.07 -0.04 -0.044
Asset Turnover 0.53 0.60 0.50 0.51 0.51 0.52 0.50 0.52 0.56 0.58 0.62 0.63 0.63 0.63 0.65 0.66 0.68 0.68 0.66 0.65 0.652
Equity Multiplier 1.32 1.32 1.25 1.25 1.25 1.25 1.26 1.26 1.26 1.26 1.29 1.29 1.29 1.29 1.30 1.30 1.30 1.30 1.30 1.30 1.301
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-4.59 $-4.11 $-0.52 $-0.79 $-1.25 $-1.47 $-1.45 $-1.51 $-1.48 $-1.90 $-2.15 $-2.21 $-2.00 $-1.51 $-1.50 $-1.28 $-0.68 $-0.61 $-0.34 $-0.18 $-0.18
Book Value/Share $6.73 $6.67 $7.31 $7.24 $7.20 $7.16 $7.02 $6.97 $6.90 $6.84 $6.25 $6.21 $6.17 $6.14 $5.84 $5.79 $5.70 $5.66 $6.27 $6.21 $6.35
Tangible Book/Share $6.52 $6.46 $7.04 $6.97 $6.94 $6.90 $6.78 $6.73 $6.67 $6.61 $6.07 $6.03 $6.00 $5.96 $5.67 $5.63 $5.54 $5.50 $5.74 $5.69 $5.69
Revenue/Share $3.69 $4.14 $4.38 $4.42 $4.38 $4.41 $4.50 $4.64 $4.87 $5.02 $5.22 $5.24 $5.26 $5.22 $5.02 $5.09 $5.18 $5.11 $5.06 $4.98 $4.98
FCF/Share $-2.40 $-2.28 $-1.10 $-1.14 $-1.42 $-1.41 $-1.44 $-1.08 $-1.01 $-0.95 $-0.54 $-0.62 $-0.28 $0.21 $-0.06 $0.36 $0.46 $0.65 $1.02 $0.95 $0.95
OCF/Share $-1.70 $-1.42 $-0.19 $-0.34 $-0.51 $-0.36 $-0.29 $-0.15 $-0.10 $-0.23 $-0.13 $-0.22 $-0.06 $0.32 $0.05 $0.46 $0.54 $0.71 $1.07 $1.00 $1.00
Cash/Share $6.04 $5.99 $5.25 $5.20 $5.17 $5.15 $3.75 $3.72 $3.68 $3.65 $3.28 $3.26 $3.24 $3.22 $3.24 $3.21 $3.16 $3.13 $4.12 $4.08 $4.21
EBITDA/Share $-4.28 $-3.78 $-0.22 $-0.48 $-0.94 $-1.13 $-1.12 $-1.18 $-1.11 $-1.51 $-1.73 $-1.76 $-1.56 $-1.09 $-1.10 $-0.91 $-0.31 $-0.25 $-0.10 $-0.05 $-0.05
Debt/Share $0.57 $0.57 $0.73 $0.73 $0.72 $0.72 $0.83 $0.82 $0.82 $0.81 $0.80 $0.80 $0.79 $0.79 $0.68 $0.67 $0.66 $0.66 $1.24 $1.23 $1.23
Net Debt/Share $-5.47 $-5.42 $-4.52 $-4.47 $-4.45 $-4.43 $-2.92 $-2.90 $-2.87 $-2.84 $-2.47 $-2.46 $-2.44 $-2.43 $-2.56 $-2.53 $-2.50 $-2.48 $-2.88 $-2.85 $-2.85
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 5.775
Altman Z-Prime snapshot only 10.108
Piotroski F-Score 4 4 5 5 5 5 3 3 3 3 2 2 3 5 6 6 6 5 5 5 5
Beneish M-Score -3.16 -3.55 -2.05 -2.07 -2.09 -2.42 -2.93 -3.04 -2.98 -3.11 -3.54 -3.60 -3.62 -3.65 -3.74 -3.76 -3.42 -3.50 -2.66 -2.53 -2.531
Ohlson O-Score snapshot only -10.072
ROIC (Greenblatt) snapshot only -3.40%
Net-Net WC snapshot only $3.43
EVA snapshot only $-73640770.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A
Credit Score 61.14 61.93 62.27 62.49 64.08 64.05 65.71 64.92 65.42 65.30 65.49 65.05 65.74 71.27 59.31 49.82 60.46 65.52 73.22 71.90 71.899
Credit Grade snapshot only 6
Credit Trend snapshot only 22.074
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 71
Sector Credit Rank snapshot only 67

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms